About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
ACOR - Acorda Therapeutics| Previous Close | $0.70 | Open | $0.71 |
| Volume | 1.19M | Market Cap | 33.44M |
| Yield | Last Dividend |
| Acorda Reports Second Quarter 2020 Finan... | 08/04/20 |
| Acorda Therapeutics, Inc. (NASDAQ: ACOR) today provided a business update and reported its financial results for the second quarter ended June 30, 202 | |
| The Week Ahead In Biotech: Novavax Coron... | 08/02/20 |
| Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flo... | |
| Acorda Second Quarter 2020 Update: Webca... | 07/28/20 |
| Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast in conjunction with its second quarter 2020 update and financial resu | |
| The Daily Biotech Pulse: Moderna To Kick... | 07/15/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alt... | |
| Is the Options Market Predicting a Spike... | 06/09/20 |
| Investors need to pay close attention to Acorda Therapeutics (ACOR) stock based on the movements in the options market lately. | |
| Acorda (ACOR) Down 11.8% Since Last Earn... | 06/04/20 |
| Acorda (ACOR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| Acorda (ACOR) Q1 Earnings Lag Estimates,... | 05/06/20 |
| Acorda's (ACOR) earnings and revenues fall shy of estimates in the first quarter of 2020. The company withdraws revenue view for its Parkinson's disea... | |
| Acorda Therapeutics (ACOR) Reports Q1 Lo... | 05/05/20 |
| Acorda (ACOR) delivered earnings and revenue surprises of -45.71% and -28.58%, respectively, for the quarter ended March 2020. Do the numbers hold clu... | |
| Acorda Reports First Quarter 2020 Financ... | 05/05/20 |
| ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (NASDAQ: ACOR) today provided a business update and reported its financial results for the f... | |
| The Week Ahead In Biotech: Smid-Cap Earn... | 05/03/20 |
| Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma nam... | |
| Acorda First Quarter 2020 Update: Webcas... | 04/28/20 |
| ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast in conjunction with its first quarter... | |
| Acorda (ACOR) to Report Q1 Earnings: Wha... | 04/24/20 |
| During Acorda's (ACOR) upcoming Q1 earnings call, investor focus will be on the sales uptake of its newly-launched Parkinson's disease drug, Inbrija. | |
| Global Multiple Sclerosis Drugs Market S... | 04/17/20 |
| DUBLIN--(BUSINESS WIRE)--The "Multiple Sclerosis Drugs Market Global Report 2020" report has been added to ResearchAndMarkets.com's offering. The glob... | |
| Acorda Therapeutics (ACOR) Flat As Marke... | 04/16/20 |
| Acorda Therapeutics (ACOR) closed the most recent trading day at $1.06, making no change from the previous trading session. | |
| The Inhaler Market in the United States ... | 04/14/20 |
| DUBLIN--(BUSINESS WIRE)--The "US Inhaler Market 2019-2025" report has been added to ResearchAndMarkets.com's offering. The US inhaler market is antici... | |
| Why Is Acorda (ACOR) Down 54.7% Since La... | 03/14/20 |
| Acorda (ACOR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| The Daily Biotech Pulse: Roche Obtains F... | 03/13/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) ... | |
| The Daily Biotech Pulse: Mesoblast To Te... | 03/10/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) A... | |
| The Daily Biotech Pulse: Gilead Kicks Of... | 02/27/20 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs o... | |
| The Daily Biotech Pulse: Moderna Ships C... | 02/25/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) ... | |
| Acorda (ACOR) Q4 Earnings Top Estimates,... | 02/14/20 |
| Acorda (ACOR) beat earnings and revenue estimates in the fourth quarter of 2019. | |
| Acorda (ACOR) Beats Earnings & Revenues ... | 02/13/20 |
| Acorda (ACOR) reports lower-than-expected loss in the fourth quarter while revenues beat estimates. | |
| Acorda Therapeutics Provides Business Up... | 02/13/20 |
| ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today provided a business update and reported its financial results for the f... | |
| What's in Store for Acorda (ACOR) This E... | 02/10/20 |
| During Acorda's (ACOR) Q4 earnings call, investor focus will be on the sales uptake of its newly-launched Parkinson's disease drug Inbrija. | |
| Acorda Fourth Quarter/Year End 2019 Upda... | 01/30/20 |
| ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast in conjunction with its fourth quarte... | |
| Acorda Provides 2019 Highlights and 2020... | 01/15/20 |
| ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today provided 2019 highlights and 2020 guidance and priorities at the 38th A... | |
| The Daily Biotech Pulse: Acorda Surges A... | 01/03/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Jan. 2) A... | |
| Acorda Therapeutics Completes Exchange o... | 12/26/19 |
| Acorda Therapeutics, Inc. (Nasdaq: ACOR) (???Acorda??? or the ???Company???) today announced it has successfully completed its previously announced pr... | |
| Acorda (ACOR) Down 13.5% Since Last Earn... | 12/04/19 |
| Acorda (ACOR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| Acorda Therapeutics Elects John Kelley C... | 11/27/19 |
| ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (NASDAQ: ACOR) today announced that its Board of Directors has elected John Kelley to serve ... | |
| Date | 2020-08-04 (AMC) | Est. (EPS/Rev.) | ($0.48)/ 27.5M |
| Actual (EPS/Rev.) | $-0.35/ $33.62 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
| LavaPit | Steve Pitkin | 57.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
